Our results showed that ACP supplementation significantly decreased the hepatic levels of MDA and increased the activities of SOD, CAT, and GSH-PX, indicating that ACP supplementation could alleviate the NAFLD through elevating antioxidant capacity. Here, CAT is linked to metabolic dysfunction-associated steatotic liver disease.